Press Releases

Accuray to Present at JP Morgan 33rd Annual Healthcare Conference SUNNYVALE, Calif., December 16, 2014 – Accuray Incorporated (Nasdaq: ARAY), announced today that its management is scheduled to present at the JP Morgan 33rd Annual Healthcare Conference in San Francisco on Monday, January 12, 2015 at 4:00 p.m. PST/7:00 p.m. EST. Read More »
First CyberKnife® Full-Body Radiosurgery System in Manhattan Now Treating Patients SUNNYVALE, Calif., November 18, 2014 – Accuray Incorporated (Nasdaq: ARAY) announced today that the first CyberKnife® System in Manhattan is now treating patients at Winthrop University Hospital’s NYCyberKnife Center. Winthrop’s decision to install the latest generation CyberKnife M6™ System reinforces its growing reputation as a dedicated radiosurgery device that delivers extremely precise full-body treatments while maximizing patients' quality of life during and after treatment. Read More »
Accuray to Participate in Brean Capital’s 2014 Life Science Conference SUNNYVALE, Calif., November 10, 2014 – Accuray Incorporated (Nasdaq: ARAY), announced today that its management is scheduled to participate in the Brean Capital 2014 Life Science Conference in New York City on Monday, November 24, 2014. Read More »
Studies Support the Use of the CyberKnife® System as a Safe and Effective Option to Treat Neurological Diseases SUNNYVALE, Calif., November 3, 2014 -- Accuray Incorporated (Nasdaq: ARAY) announced that studies presented at the 15th European Congress of Neurosurgical Societies (EANS) in Prague, October 12 – 17, 2014 reinforce the benefits of the CyberKnife® Robotic Radiosurgery System for the treatment of neurological diseases such as meningiomas, acoustic neuromas, trigeminal neuralgia, and spinal tumors. Read More »
Accuray and Lausanne University Hospital Join Forces to Offer Patients Personalized Radiation Therapy Treatments SUNNYVALE, Calif., October 31, 2014 -- Accuray Incorporated (Nasdaq: ARAY) today announced a long-term collaboration with Lausanne University Hospital, Switzerland covering the CyberKnife® and TomoTherapy® Systems. The alliance is based on a mutual commitment to ongoing research in radiation oncology and the development of innovative treatments that improve the quality of life for cancer patients. Read More »
Accuray Reports Financial Results for First Quarter of Fiscal Year 2015 SUNNYVALE, Calif., October 29, 2014 – Accuray Incorporated (Nasdaq: ARAY) announced today financial results for the first fiscal quarter ended September 30, 2014. Read More »
Accuray to Report Financial Results for First Quarter Fiscal 2015 SUNNYVALE, Calif., October 8, 2014 – Accuray Incorporated (Nasdaq: ARAY) announced today that it will report results for its first quarter ended September 30, 2014 on October 29, 2014 after the market closes. Read More »
Studies Support Growing Use of the Accuray TomoTherapy® System for Breast Cancer to Improve Tumor Control with Reduced Toxicities SUNNYVALE, Calif., September 18, 2014 – Accuray Incorporated (Nasdaq: ARAY) announced today that studies presented at the 56th Annual American Society for Radiation Oncology (ASTRO) Meeting in San Francisco, September 14 – 17, 2014 continue to reinforce broad-based healthcare professional support of the clinical and quality of life benefits the CyberKnife® and TomoTherapy® Systems deliver. A variety of indications including breast, prostate, lung, brain, and head and neck cancers were featured at the meeting, further positioning Accuray as a leader in precise, innovative tumor treatments. Read More »

Pages